The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Angiotensin I

Angiotensin I

Angiotensin I is a decapeptide (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) that is produced from angiotensinogen by the action of renin.
It is converted to angiotensin II by angiotensin-converting enzyme (ACE).
Angiotensin I has some physiological activity, but is less potent than angiotensin II in causing vasoconstriction and aldosterone secretion.
Discover optimized research protocols for Angiotensin I using PubCompare.ai's AI-driven platform, which makes it easy to locate protocols from literature, pre-prints, and patents.
Leverage AI-driven comparisons to identify the best protocols and products for enhanced reprodbcibility and accuracy in your research.

Most cited protocols related to «Angiotensin I»

Highly deuterated peptides (Waters MassPREP Peptide Standard containing RASG-1, bradykinin, and angiotensin I and II) were prepared by dissolving the lyophilized peptides into D2O that was adjusted to pD 2.5 with DCl. Peptides were allowed to deuterate at 20 °C for two hours before infusion directly into the instrument in 50:50 D2O:acetonitrile using a syringe pump.
Labeled cytochrome c (462 µM stock solution in 20 mM Tris, 100 mM NaCl and 3 mM DTT) was diluted to usable concentrations of 64 and 12.8 µM for HPLC and UPLC, respectively. Deuterium exchange was initiated by adding a 15-fold excess of 99% deuterium oxide buffer (20 mM Tris, 100 mM NaCl and 3 mM DTT) at 21 °C. At each exchange-in time point an aliquot (100 picomoles for HPLC, 20 picomoles for UPLC) from the exchange reaction was transferred to a separate tube containing an equal volume of quench buffer (300 mM potassium phosphate, pH 2.6, H2O). Quenched samples were immediately analyzed. Highly deuterated cytochrome c was prepared by diluting the stock solution 15-fold into D2O pD 2.5, incubating at 37 °C for 6 hours and quenching as described above.
Publication 2008
acetonitrile Angiotensin I Bradykinin Buffers Cytochromes c Deuterium Deuterium Oxide High-Performance Liquid Chromatographies Peptides potassium phosphate Sodium Chloride Syringes Tromethamine
Hypertension was produced in Wild type, RAG-1−/−, CD4−/−, CD8−/− and MCHII−/−, and OT1xRAG-1−/− male mice by infusion of angiotensin II (490 ng/kg/min) for two weeks. Blood pressure was measured both invasively using telemetry and non-invasively using the tail cuff method as previously described.3 (link) Flow cytometry, vascular reactivity in mesenteric arteries, sodium and volume challenge experiments and kidney vascular morphology analyses are described in detail in the online supplement.
Publication 2014
Angiotensin I Blood Pressure Blood Vessel Dietary Supplements Flow Cytometry Hematologic Tests High Blood Pressures Kidney Males Mesenteric Arteries Mice, House Sodium Tail Telemetry
Coomassie-stained gel spots were excised manually, washed, and digested according to previously described methods [49 (link)]. The mixture of tryptic peptides (0.5 μL) derived from each protein was spotted onto a MALDI target (384 anchorchip MTP 800 μm Anchorchip; Bruker Daltonik, Germany) together with 0.5 μL of matrix (10 mg α-cyano-4-hydroxycinnamic acid (CHCA) in 1 mL of 30% CH3CN and 0.1% aqueous CF3COOH) and left to dry (room temperature, RT) before MS analysis. Spectra were acquired on a MALDI-TOF MS (UltraFlexTrem, Bruker Daltonics, Germany) in the positive mode (target voltage 25 kV, pulsed ion extraction voltage 20 kV). The reflector voltage was set to 21 kV and the detector voltage to 17 kV. Peptide mass fingerprints (PMF) were calibrated against a standard mixture by assigning appropriate mono-isotopic masses to the peaks; that is, bradykinin (1–7), m/z 757.399; angiotensin I, m/z 1296.685; angiotensin II, m/z 1046.54; rennin-substrate, m/z 1758.93; ACTH clip (1–17), m/z 2093.086; and somatostatin, m/z 3147.471 (peptide calibration standard II, Bruker Daltonics, Germany). MS spectra were recorded automatically across the mass range m/z 700–3000 and spectra were typically the sum of 400 laser shots. The PMFs were processed using Flex AnalysisTM software (version 2.4, Bruker Daltonics, Germany) and the sophisticated numerical annotation procedure (SNAP) algorithms were used for peak detection (S/N, 3; maximum number of peaks, 100; quality factor threshold, 30). MS data were interpreted using BioTools v3.2 (Bruker Daltonics, Germany), together with the Mascot search algorithm (version 2.0.04 updated 09/05/2018; Matrix Science Ltd., UK). Mascot parameters were as follows: fixed cysteine modification with propionamide, variable modification due to methionine oxidation, one missed cleavage site (i.e., in the case of incomplete trypsin hydrolysis), and amass tolerance of 100 ppm. Identified proteins were accepted as correct if they showed a Mascot score greater than 56 and p < 0.05, sequence coverage of at least 20%, and a minimum of four matched peptides. Not all spots of interest could be identified because some proteins were of low abundance and did not yield sufficiently intense mass fingerprints, whereas others were mixtures of multiple proteins [48 (link)].
Full text: Click here
Publication 2020
Angiotensin I Angiotensin II Angiotensinogen Bradykinin Clip Coumaric Acids Cysteine Cytokinesis Exanthema Fingerprints, Peptide Hydrolysis Immune Tolerance Isotopes Methionine Peptides propionamide Proteins Somatostatin Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Trypsin Z1046
MALDI-MSI analysis was performed according to our previous study [24 (link)], with minor modifications. The flavan-3-ol standards and strawberry fruit sections were analyzed using a MALDI-TOF/TOF instrument (UltrafleXtreme, Bruker, Billerica, MA, USA) equipped with a 355 nm Nd:YAG laser, using a repetition rate of 1000 Hz. Data were acquired using a step size of 300 μm in negative-ion mode (reflector mode). The m/z values in the range of 240–1200 were measured. The laser diameter was set to the medium size. The instrument was calibrated externally using the exact m/z values of CHCA [M − H] ions (m/z 188.03532), bradykinin (1–7) [M − H] ions (m/z 755.38460), angiotensin II [M − H] ions (m/z 1044.52725), and angiotensin I [M − H] ions (m/z 1294.67025) as references. The spectra were acquired automatically using FlexImaging 4.1 software (Bruker). Normalization of spectra based on the total ion current was performed using the same software. The FlexImaging 4.1 software was also used to create two-dimensional ion-density maps and for peak analyses.
Matrix screening was performed according to our previous study [25 (link)]. Briefly, 1 µL of each standard (10 μg/mL) was mixed with equal volumes of CHCA (10 mg/mL in 70% aqueous methanol), 9AA (10 mg/mL in 70% aqueous methanol), and DAN (10 mg/mL in 80% aqueous methanol) on an ITO-coated glass slide; then, MALDI-MSI analysis was performed.
To analyze the strawberry fruit sections, frozen sections were took out from a freezer and dried in a vacuum desiccator for 30 min. Six milliliters of a DAN solution (10 mg/mL in 80% aqueous methanol) was sprayed uniformly over the section using a 0.18 mm nozzle caliber airbrush (Mr. Airbrush Custom Double Action; Mr. Hobby, Tokyo, Japan), after which MALDI-MSI analysis was performed. To investigate the spatial distribution of the identified proanthocyanidins, three different strawberry fruits were analyzed. The mass spectra and ion images of the identified flavan-3-ols in the three different strawberry fruits showed similar patterns (Supplementary Figure S3). The mass spectrum and ion images of one of the three different strawberry fruits are presented as representative data in Figure 2C–I.
To compare the intensities of the identified flavan-3-ols between the skin and vascular bundles, three sections of the same strawberry fruit were analyzed and their tissue-specific intensities were obtained using the region-of-interest function of FlexImaging 4.1 software. These data are shown in Figure 5.
Full text: Click here
Publication 2019
A 300 Angiotensin I Angiotensin II Blood Vessel Bradykinin flavan-3-ol Frozen Sections Fruit Ion Transport Mass Spectrometry Methanol Microtubule-Associated Proteins Neodymium-Doped Yttrium Aluminum Garnet Lasers Proanthocyanidins Skin Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Strawberries Tissue Specificity Vacuum

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Angiotensin I angiotensin I (1-7) ANGPT1 protein, human chloramine-T High-Performance Liquid Chromatographies Iodination Metabolism Oxidants Peptides sodium bisulfate

Most recents protocols related to «Angiotensin I»

Example 8

In this example, research shows that during the mass spectrometric detection of the 5 markers, the cationic mode should be chosen to detect angiotensin I, angiotensin II, cortisol and 18-hydrocorticosterone, while the anionic mode needs to be chosen to detect aldosterone; this is because when the cationic mode is chosen, there exists a peak diagram of cortisone, an isomer of aldosterone, nearby the detection peak of aldosterone to cause larger interference, and CV % is greater than 15%; but when the anionic mode is applied for detection, the test result is more stable and accurate, and CV% is less than 8.33%.

Full text: Click here
Patent 2024
18-Hydroxycorticosterone Aldosterone Angiotensin I Angiotensin II Cations Cortisone Hydrocortisone Isomerism Mass Spectrometry

Example 11

FIG. 15 is a paper spray mass spectrum of angiotensin I solution (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu (SEQ ID NO: 1), 10 μL, 8 μg/mL in methanol/water, 1:1, v/v) on chromatography paper (spray voltage, 4.5 kV). The inset shows an expanded view over the mass range 630-700. The protonated ([M+2H]2+) and sodium-adduct ions ([M+H+Na]2+, [M+2Na]2+) are the major ionic species.

Full text: Click here
Patent 2024
Angiotensin I arginylvaline aspartyltyrosine Ions Mass Spectrometry Methanol Paper Chromatographies Sodium
Plasma AGT concentrations were measured using a mouse AGT ELISA kit (ab245718; Abcam). Plasma renin concentrations were measured using an ELISA kit (IB59131, Immuno-Biological Laboratories Co., Ltd.) in which the angiotensin I product was determined after incubation of plasma with recombinant mouse AGT at 37°C for 1 hour.
Full text: Click here
Publication 2023
Angiotensin I Biopharmaceuticals Enzyme-Linked Immunosorbent Assay Mice, House Plasma Renin
Immediately after collection, each sample was centrifuged at 4 °C and placed on ice and stored at −80 °C until the analysis. The urine samples were also immediately stored at −80 °C until the analysis. All the measurements were conducted within 30 days of collection.
After extraction from plasma with alumina, plasma adrenaline was measured by high-performance liquid chromatography (HPLC system JASCO Corporation, Tokyo, Japan) using the procedure described previously by Hunter et al. [9 (link)] with minor modifications. A freezing point depression osmometer (model AUTO&STAT OM-6030, Arkray, Kyoto, Japan) was used to measure the plasma and urine osmolalities. The ion selective electrode method was applied to measure the plasma and urine Na+ levels, using an autoanalyzer (BM8060 JEOL Ltd, Tokyo, Japan)Furthermore, the creatininase-creatinase-sarcosine oxidase-POD method was applied for the measurement of plasma and urine creatinine levels, using the above autoanalyzer. The PRA was measured using a method based on the generation of angiotensin I in plasma samples over 60 min at 37 °C followed by the measurement of angiotensin I by a double-antibody 125I-radioimmunoassay using a gamma counter instrument (ARC 950,HITACHI Ltd, Tokyo, Japan). A double-antibody 125I-radioimmunoassay was applied to measure the plasma ADH using the gamma counter instrument (ARC 950 HITACHI Ltd, Tokyo, Japan), while a competitive solid-phase 125I-radioimmunoassay technique was applied to measure Pald, using the kit(SPAC-S Aldosterone kit, TFB inc, Tokyo, Japan).
The following equation was used to calculate the creatinine clearance: (CCr mL/min): CCr = UCr × V/PCr (UCr: urine creatinine level; PCr: plasma creatinine level; V: urine flow volume). The urinary osmolar excretion was estimated in UosmV mOsm/min, using the formula: UosmV = Uosm × V (Uosm: urine osmolality; V: urine flow volume). The osmolal clearance (in Cosm mL/min) was computed using the equation: Cosm = UosmV / Posm (UosmV: urinary osmolar excretion; Posm: plasma osmolality).
The following formula was used to estimate the free water clearance (in CH2O mL/min): CH2O = V-Cosm (V: urine flow volume; Cosm: osmolal clearance). Finally, we used the following formula to determine the fractional excretion of Na+ (FENa%): FENa = [UNa+ × PCr]/[PNa+ × UCr] × 100 (PNa+: plasma Na+; UNa+: urinary Na+; PCr: plasma creatinine; UCr: urinary creatinine level).
Full text: Click here
Publication 2023
Aldosterone Angiotensin I creatinase creatininase Creatinine Diuresis Epinephrine Gamma Rays High-Performance Liquid Chromatographies Immunoglobulins Ion-Selective Electrodes Osmolarity Oxide, Aluminum Plasma Radioimmunoassay Sarcosine Oxidase Urine
The Ang-I and Ang-II were synthesized, purified, and identified according to the method mentioned in Section 2.5. To a mixture of Ang-I (1 μg) and peptide substrate (1 μg) in 50 µL of borate buffe (200 mM borate buffer, 300 mM NaCl, pH 8.3), 20 µL of ACE (0.05 mU/µL) was added. The mixture was incubated at 37 °C and monitored using LC-MS/MS at 1, 2, 3, 4, 6, and 10 h. The LC separation was performed on Syncronis C18 column (150 mm × 2.1 mm, 5 µm, Thermo Scientific) and eluted with the mobile phase A (5% ACN and 0.1% FA) and B (95% ACN and 0.1% FA) at a flow rate of 350 µL/min. The elution gradient was programmed as (i) 0–5 min, isocratic elution with 5% B; (ii) 5–20 min, linear gradient from 5% to 55% B; (iii) 20–22 min, linear gradient from 55% to 80% solution B; and finally (iv) 22–30 min, isocratic elution maintained at 80% solution B. The degradation of Ang-I and the formation of Ang-II were analyzed using selective ion chromatogram (SIC) on a triple quadrupole mass analyzer (TSQ, Thermo Scientific). The percentage of the remaining angiotensin I (RA%) at each time point was calculated as AI/(AI + AII) × 100%, where AI is the SIC peak area of remaining Ang-I and AII is the peak area of the resulting Ang-II.
Full text: Click here
Publication 2023
Angiotensin I Borates Buffers Peptides Sodium Chloride Tandem Mass Spectrometry

Top products related to «Angiotensin I»

Sourced in United States
Angiotensin I is a laboratory product used for research purposes. It is a peptide hormone that plays a role in the regulation of blood pressure. The core function of Angiotensin I is to serve as a substrate for the enzyme angiotensin-converting enzyme (ACE), which converts Angiotensin I into Angiotensin II, an important regulator of blood pressure and fluid balance in the body.
Sourced in United States, Germany, United Kingdom, Canada, Brazil, Australia, France
Bradykinin is a lab equipment product manufactured by Merck Group. It is a peptide that plays a role in the regulation of blood pressure and inflammation. Bradykinin functions by interacting with specific receptors on cell surfaces.
Sourced in United States, Germany, Macao, Japan, China, Canada, Switzerland
Angiotensin II is a laboratory reagent used for research purposes. It is a peptide hormone that plays a role in the regulation of blood pressure and fluid balance in the body. Angiotensin II is commonly used in scientific research to study its physiological effects and its potential therapeutic applications.
Sourced in Germany
The ACTH clip 18–39 is an analytical standard used for the identification and quantification of adrenocorticotropic hormone (ACTH) in biological samples. It is a synthetic peptide fragment corresponding to the amino acid sequence 18 to 39 of the ACTH protein. This product is intended for research use only and is not for use in diagnostic procedures.
Sourced in United States
Neurotensin is a laboratory reagent produced by Merck Group. It is a neuropeptide that functions as a neurotransmitter and neuromodulator in the central nervous system. Neurotensin is used in research applications to study its physiological and pharmacological effects.
Sourced in United States, United Kingdom
Substance P is a laboratory reagent used for research purposes. It is a neuropeptide that functions as a neurotransmitter or neuromodulator in the central and peripheral nervous systems. Substance P is involved in the transmission of pain and other sensory information.
Sourced in Germany, United States, Italy, India, China, United Kingdom, France, Poland, Spain, Switzerland, Australia, Canada, Brazil, Sao Tome and Principe, Ireland, Belgium, Macao, Japan, Singapore, Mexico, Austria, Czechia, Bulgaria, Hungary, Egypt, Denmark, Chile, Malaysia, Israel, Croatia, Portugal, New Zealand, Romania, Norway, Sweden, Indonesia
Acetonitrile is a colorless, volatile, flammable liquid. It is a commonly used solvent in various analytical and chemical applications, including liquid chromatography, gas chromatography, and other laboratory procedures. Acetonitrile is known for its high polarity and ability to dissolve a wide range of organic compounds.
Sourced in Germany, United States, Italy, United Kingdom, France, Spain, China, Poland, India, Switzerland, Sao Tome and Principe, Belgium, Australia, Canada, Ireland, Macao, Hungary, Czechia, Netherlands, Portugal, Brazil, Singapore, Austria, Mexico, Chile, Sweden, Bulgaria, Denmark, Malaysia, Norway, New Zealand, Japan, Romania, Finland, Indonesia
Formic acid is a colorless, pungent-smelling liquid chemical compound. It is the simplest carboxylic acid, with the chemical formula HCOOH. Formic acid is widely used in various industrial and laboratory applications.
Sourced in United States, Germany, France, United Kingdom, Japan, Sao Tome and Principe, Poland, Macao, Saudi Arabia
α-cyano-4-hydroxycinnamic acid is a chemical compound used in various laboratory applications. It serves as a matrix for matrix-assisted laser desorption/ionization (MALDI) mass spectrometry analysis. The compound facilitates the ionization of analyte molecules during the MALDI process.
Sourced in Germany
The ACTH clip 1–17 is a laboratory product manufactured by Bruker. It is a peptide fragment derived from the adrenocorticotropic hormone (ACTH) sequence. The core function of this product is to serve as a research tool for scientific investigations, without any interpretation or extrapolation on its intended use.

More about "Angiotensin I"

Angiotensin I is a crucial peptide hormone in the renin-angiotensin-aldosterone system (RAAS), playing a pivotal role in regulating blood pressure and fluid balance.
This decapeptide (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) is cleaved from the precursor angiotensinogen by the enzyme renin, resulting in the formation of Angiotensin I.
While Angiotensin I has some physiological activity, it is less potent than its downstream product, Angiotensin II, in terms of causing vasoconstriction and stimulating aldosterone secretion.
Angiotensin II is generated from Angiotensin I through the action of the Angiotensin-Converting Enzyme (ACE).
To optimize research protocols for Angiotensin I, researchers can leverage the AI-driven platform PubCompare.ai.
This tool makes it easy to locate protocols from the literature, preprints, and patents, allowing researchers to identify the best protocols and products for enhanced reproducibility and accuracy in their studies.
When conducting Angiotensin I research, it is also important to consider related peptides and compounds, such as Bradykinin, Angiotensin II, ACTH clip 18–39, Neurotensin, Substance P, Acetonitrile, Formic acid, α-cyano-4-hydroxycinnamic acid, and ACTH clip 1–17.
Understanding the interactions and roles of these related molecules can provide valuable insights into the complex physiological processes involving Angiotensin I.
By utilizing the AI-driven capabilities of PubCompare.ai and incorporating a comprehensive understanding of Angiotensin I and its related terms, researchers can optimize their experimental protocols, enhance reproducibility, and advance their understanding of this critical peptide hormone and its involvement in cardiovascular and renal physiology.